Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma
- PMID: 34127329
- DOI: 10.1016/j.ejso.2021.06.005
Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma
Abstract
Background: Evaluation of recurrence pattern and risk factors for recurrence are essential for good rates of survival after upfront pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC).
Methods: This retrospective study included 167 consecutive patients who underwent upfront PD for resectable PDAC between 2000 and 2018. Postoperative recurrences were classified into three patterns according to initial recurrence site: isolated locoregional, isolated distant, and simultaneous locoregional and distant recurrences.
Results: This study found 114 patients who developed postoperative recurrence (68.3%), including 37 patients with isolated locoregional recurrence (32.5%), 67 patients with isolated distant recurrence (58.8%), and 10 patients with simultaneous locoregional and distant recurrences (6.0%). When locoregional recurrence was classified based on the location of recurrent lesions, locoregional recurrence most commonly occurred around the superior mesenteric artery (SMA) (70.2%), followed by around the hepatic artery (25.5%) and in the paraaortic region (14.9%). Multivariate analyses showed that complete circumferential lymphadenectomy around the SMA, including not only the right side, but also the left side, was an independent factor for reduction of locoregional recurrence (P = 0.019, odds ratio [OR]: 2.217). Lymph node metastasis was an independent risk factor for both locoregional (P < 0.001, OR: 3.686) and distant recurrences (P < 0.001, OR: 4.315). Non-completion of postoperative adjuvant therapy was a risk factor for distant recurrence (P < 0.001, OR: 3.748).
Conclusion: Based on our data, complete circumferential lymphadenectomy around the SMA might contribute to local control, and multidisciplinary treatment including neoadjuvant therapy might be needed for resectable PDAC with high risk for recurrence.
Keywords: Circumferential lymphadenectomy around the SMA; Distant recurrence; Locoregional recurrence; Lymph node metastasis; Pancreatic ductal adenocarcinoma; Pancreatoduodenectomy.
Copyright © 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
Comment in
-
Correspondence regarding "Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma".Eur J Surg Oncol. 2022 Jan;48(1):302. doi: 10.1016/j.ejso.2021.11.005. Epub 2021 Nov 16. Eur J Surg Oncol. 2022. PMID: 34802861 No abstract available.
-
Reply to: Correspondence reading "Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma".Eur J Surg Oncol. 2022 Jan;48(1):300-301. doi: 10.1016/j.ejso.2021.11.008. Epub 2021 Nov 11. Eur J Surg Oncol. 2022. PMID: 34819244 No abstract available.
-
Does Extended Lymphadenectomy Help in Pancreatic Cancer?Ann Surg Oncol. 2022 Apr;29(4):2131-2133. doi: 10.1245/s10434-022-11370-1. Epub 2022 Feb 4. Ann Surg Oncol. 2022. PMID: 35122169 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
